StockWatch
·
Healthcare Research- Analytics & Technology
Auditor29 Apr 2026, 07:11 pm

Syngene Appoints S. R. Batliboi & Associates LLP as Statutory Auditors

AI Summary

Syngene International Ltd.'s Board of Directors approved the audited financial results for the quarter and year ended March 31, 2026. They recommended a final dividend of ₹1.25 per equity share (face value ₹10) for FY26, with June 26, 2026, as the record date. Subject to shareholder approval, M/s S. R. Batliboi & Associates LLP were appointed as statutory auditors for a five-year term, commencing from the 33rd Annual General Meeting (AGM) until the 2031 AGM. The 33rd AGM is scheduled for July 29, 2026. The board also approved managerial remuneration for Ms. Kiran Mazumdar-Shaw.

Key Highlights

  • Board approved Q4 and FY26 audited financial results.
  • Recommended final dividend of ₹1.25 per equity share for FY26.
  • S. R. Batliboi & Associates LLP appointed as statutory auditors for 5 years.
  • 33rd Annual General Meeting scheduled for July 29, 2026.